ST
IBB icon

Spot Trading’s iShares Biotechnology ETF IBB Stock Holding History

Spot Trading’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.17M Sell
10,518
-28,239
-73% -$3.02M 0.02% 1052
2017
Q2 		$4.01M Buy
38,757
+1,860
+5% +$183K 0.08% 305
2017
Q1 		$3.61M Sell
36,897
-40,536
-52% -$3.88M 0.12% 151
2016
Q4 		$6.85M Buy
+77,433
New +$7.05M 0.16% 132
2016
Q1 		– Sell
-13,434
Closed -$1.2M – 3663
2015
Q4 		$1.51M Sell
13,434
-80,553
-86% -$8.74M 0.02% 1194
2015
Q3 		$9.5M Buy
93,987
+76,707
+444% +$9.2M 0.09% 261
2015
Q2 		$2.13M Buy
17,280
+17,271
+191,900% +$2.07M 0.02% 1102
2015
Q1 		$1K Sell
9
-3
-25% -$331 ﹤0.01% 3783
2014
Q4 		$1K Hold
12
– – ﹤0.01% 3885
2014
Q3 		$1K Buy
+12
New +$1.05K ﹤0.01% 4234
2014
Q2 		– Sell
-15
Closed -$1.18K – 4661
2014
Q1 		$1K Buy
+15
New +$1.25K ﹤0.01% 4121
2013
Q4 		– Sell
-22,989
Closed -$1.63M – 4100
2013
Q3 		$1.61M Buy
+22,989
New +$1.51M 0.01% 1554

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Spot Trading's IBB Position: Q3 2017 in Review

Spot Trading reduced its iShares Biotechnology ETF (IBB) stake by 73% in Q3 2017, selling an estimated $3.02M and leaving 10,518 shares worth $1.17M. The position accounts for 0.02% of the portfolio, ranked #1052.

Spot Trading first reported a position in IBB in Q3 2013 and has held it in 12 quarters since. The position peaked at $9.5M in Q3 2015. 584 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

  • Spot Trading held 10,518 shares of iShares Biotechnology ETF worth $1.17M as of Q3 2017.
  • Spot Trading sold 28,239 iShares Biotechnology ETF shares in Q3 2017, an estimated $3.02M.
  • iShares Biotechnology ETF made up 0.02% of Spot Trading's portfolio in Q3 2017, its #1052 holding.
  • Spot Trading first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 12 quarters since.
  • Spot Trading's iShares Biotechnology ETF position peaked at $9.5M in Q3 2015.
  • 584 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.